Search
for
Sort by
Research 571–600 of 1000+
- Immune-Molecular Link between Thyroid and Skin Autoimmune Diseases: A Narrative Review
- Serum vitamin D level and disease severity of alopecia areata: A meta-regression analysis
- Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist
- Hair loss and its management in children
- Cutaneous Markers of Disorders Affecting Adult Horses
- Erythematous cutaneous nodules caused by adulterated cocaine
- A Cell Membrane-Level Approach to Cicatricial Alopecia Management: Is Caveolin-1 a Viable Therapeutic Target in Frontal Fibrosing Alopecia?
- “Structural imprinting” of the cutaneous immune effector function
- Effects of Topical application of Astragalus membranaceus in Spontaneous Alopecia Mice Model
- Computational derivation of a molecular framework for hair follicle biology from disease genes
- Inflammatory loops in the epithelial–immune microenvironment of the skin and skin appendages in chronic inflammatory diseases
- Oxidative stress and alopecia areata
- Evaluation of Animal Models Suitable for Hair Research and Regeneration
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Biotechs target stagnant baldness market
- Filaggrin mutations as an archetype for understanding the pathophysiology of atopic dermatitis
- Rheumatologic Manifestations of Pregnancy
- Applications of Antioxidant Nanoparticles in Immune-Mediated Inflammatory Diseases
- Effect of Particle Size on Physical Properties, Dissolution, In Vitro Antioxidant Activity, and In Vivo Hepatoprotective Properties of Tetrastigma hemsleyanum Diels et Gilg Powders
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review
- Current and future pharmacotherapy for alopecia areata
- Etiopathogenesis of Alopecia Areata
- The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases
- HuR ablation destabilizes Foxp3 mRNA and impairs regulatory T cell function, contributing to an autoimmune phenotype
- Design and characterization of AgVO3-HAP/GO@PCL ceramic-based scaffolds for enhanced wound healing and tissue regeneration
- Transcriptome sequencing reveals the expression profiles of lncRNAs and mRNAs in goat skin tissues with different types of wool coats
- Performance exploration of multi-gene panels of alopecia areata susceptibility and drug-binding targets
- An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
- The interplay of oxidative stress and immune dysfunction in Hashimoto’s thyroiditis and polycystic ovary syndrome: a comprehensive review